BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22311925)

  • 1. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
    O'Hara JR; Feener TD; Fischer CD; Buret AG
    Infect Immun; 2012 Apr; 80(4):1563-71. PubMed ID: 22311925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.
    Ghadimi D; Vrese Md; Heller KJ; Schrezenmeir J
    Inflamm Bowel Dis; 2010 Mar; 16(3):410-27. PubMed ID: 19714766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling.
    Sun X; Threadgill D; Jobin C
    Gastroenterology; 2012 Jan; 142(1):86-95.e5. PubMed ID: 21963787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion.
    Wine E; Chan VL; Sherman PM
    Pediatr Res; 2008 Dec; 64(6):599-604. PubMed ID: 18679160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling.
    Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
    PLoS One; 2012; 7(7):e40761. PubMed ID: 22808254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.
    Saksena S; Goyal S; Raheja G; Singh V; Akhtar M; Nazir TM; Alrefai WA; Gill RK; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1115-23. PubMed ID: 21350189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.
    Sun X; Jobin C
    J Infect Dis; 2014 Oct; 210(7):1145-54. PubMed ID: 24620022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB.
    Zheng J; Meng J; Zhao S; Singh R; Song W
    Infect Immun; 2008 Oct; 76(10):4498-508. PubMed ID: 18644884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection.
    Stahl M; Ries J; Vermeulen J; Yang H; Sham HP; Crowley SM; Badayeva Y; Turvey SE; Gaynor EC; Li X; Vallance BA
    PLoS Pathog; 2014 Jul; 10(7):e1004264. PubMed ID: 25033044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
    Dong L; Li J; Liu Y; Yue W; Luo X
    J Gastroenterol Hepatol; 2012 Jan; 27(1):110-9. PubMed ID: 21722182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects.
    Fűri I; Sipos F; Germann TM; Kalmár A; Tulassay Z; Molnár B; Műzes G
    World J Gastroenterol; 2013 Jul; 19(26):4119-26. PubMed ID: 23864774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni.
    Chen ML; Ge Z; Fox JG; Schauer DB
    Infect Immun; 2006 Dec; 74(12):6581-9. PubMed ID: 17015453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.
    Yu ZT; Nanthakumar NN; Newburg DS
    J Nutr; 2016 Oct; 146(10):1980-1990. PubMed ID: 27629573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation.
    Lamb-Rosteski JM; Kalischuk LD; Inglis GD; Buret AG
    Infect Immun; 2008 Aug; 76(8):3390-8. PubMed ID: 18490463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
    Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
    BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice.
    Bereswill S; Alutis ME; Grundmann U; Fischer A; Göbel UB; Heimesaat MM
    PLoS One; 2016; 11(6):e0158020. PubMed ID: 27322540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis.
    Schmitt H; Ulmschneider J; Billmeier U; Vieth M; Scarozza P; Sonnewald S; Reid S; Atreya I; Rath T; Zundler S; Langheinrich M; Schüttler J; Hartmann A; Winkler T; Admyre C; Knittel T; Dieterich Johansson C; Zargari A; Neurath MF; Atreya R
    J Crohns Colitis; 2020 May; 14(4):508-524. PubMed ID: 31630153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.